ClinicalTrials.Veeva

Menu

Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat (ESWT)

I

Indústria Brasileira Equipamentos Médicos (IBRAMED)

Status

Completed

Conditions

Cellulitis
Lipodystrophy
Adiposity

Treatments

Device: THORK Shock Wave® (Extracorporeal shock waves)

Study type

Interventional

Funder types

Industry

Identifiers

NCT03275259
Ibramed -SW

Details and patient eligibility

About

PURPOSE: To evaluate the efficacy of shock waves extracorporea in improving body contour,decrease fat localized and appearance of gynoid lipodystrophy.

SUBJECTS AND METHODS: A prospective and comparative longitudinal clinical study will be performed in 30 women with localized fat and gynoid lipodystrophy. Patients will be submitted data collection and assessments and before and after treatment.

HYPOTHESES: It is expected that the patients will present improvement in the body contour, decrease fat localized and in the picture of the gynoid lipodystrophy after of the therapies.

STATISTICAL ANALYSIS: A descriptive analysis will be done before and after vibration-oscillatory therapy, with frequency tables for categorical and descriptive variables (mean, standard deviation, median, minimum and maximum values) for continuous or numerical variables. In order to compare the main variables between the groups and the collection times, the analysis of variance (ANOVA) for repeated measurements will be used. Tukey's test will be used to compare groups. The level of significance adopted for the statistical tests will be 5% or p <0.05.

Full description

After signing the informed consent, the participants will be evaluated by two physiotherapists where the data collected will be personal data, anthropometrics and complementary diagnostic tests, such as: ultrasound diagnosis to evaluate the thickness of the adipose tissue and Cutomiter analysis of the Viscoelasticity of skin. They then started treatment with another physiotherapist who will perform the following study protocol: placing a light layer of neutral gel on the treatment area, applying extracorporeal shock waves with the stainless steel tip with 180mJ of energy totaling 4 thousand shots , in abdomens, buttocks and posterior thigh and 2 thousand shots in flanks, then performs the change of the tip to the plastic and performs 2 thousand shots in the regions of abdomens, buttocks, posterior thigh emil shots in the region of flanks. The protocol will be performed twice a week for 1 and 20 hours each, totaling 10 sessions.

Enrollment

30 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women older than 18 years of age up to premenopausal age (50 years of age).
  • With body mass index considered eutrophic and / or overweight.
  • Patients with lipodystrophy and localized abdominal fat.
  • non smokers.
  • Who agree to participate and sign the informed consent form.

Exclusion criteria

  • Male gender.
  • Possible.
  • Haemophilia carriers and hemorrhagic disorders.
  • Carriers diabetes mellitus.
  • Women in menopause.
  • Performed aesthetic treatment in the gluteal, thigh and abdominal regions in the last 1 months.
  • Patients with skin lesions, such as dermatitis and dermatoses.
  • Patients with acute deep vein thrombosis (DVT).
  • About or close to cancerous lesions.
  • Patients with cardiac pacemaker or other implanted electronic device.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Extracorporeal shock waves
Experimental group
Description:
Composed of 30 female patients with glandular lipodystrophy in the buttocks and posterior thigh and fat located in abdomen and flanks that received the treatment of extracorporeal shock waves with energy between 100 and 180mJ, frequency of 15Hz and 6000 shots in abdomen, glutes and thigh Back and flanks 3000 shots with radial applicator and 15mm tip. The treatment is performed twice a week for 1 hour and 30 minutes each session.
Treatment:
Device: THORK Shock Wave® (Extracorporeal shock waves)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems